Clinical Assessment and Pharmacotherapy of the Alcohol Withdrawal Syndrome

Author(s):  
Claudio A. Naranjo ◽  
Edward M. Sellers
1982 ◽  
Vol 140 (5) ◽  
pp. 523-525 ◽  
Author(s):  
Julius D. A. Makanjuola ◽  
Brian Faragher ◽  
David W. Rees

SummaryThe pattern and severity of alcohol withdrawal in 49 alcohol dependent subjects admitted to the Manchester Detoxification Centre are described. Assessment over 10 days involved the use of the Selected Severity Assessment Scale (SSA) and allocation of patients to subgroups of the alcohol withdrawal syndrome. There were associations between tremor, clouding of sensorium, hallucinations and convulsions (items of the SSA) and the four pre-delirious clinical sub-groups identified. We concluded that clinical assessment of the pre-delirious stage took into account these four variables and that there was little value in the routine use of the SSA on a unit such as ours.


1958 ◽  
Vol 19 (1) ◽  
pp. 118-124 ◽  
Author(s):  
Lincoln Godfrey ◽  
Martin D. Kissen ◽  
Thomas M. Downs

2021 ◽  
Vol 220 ◽  
pp. 108536 ◽  
Author(s):  
Ildikó Katalin Pribék ◽  
Ildikó Kovács ◽  
Bettina Kata Kádár ◽  
Csenge Sára Kovács ◽  
Mara J. Richman ◽  
...  

2020 ◽  
Vol 46 (11) ◽  
pp. 656-658
Author(s):  
Rachel M. Smith ◽  
Brian Benzio ◽  
Andrew L. Hendrickson ◽  
Evan D. Telford ◽  
Andrew J. Franck

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Tessa L. Steel ◽  
Shewit P. Giovanni ◽  
Sarah C. Katsandres ◽  
Shawn M. Cohen ◽  
Kevin B. Stephenson ◽  
...  

Abstract Background The Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar) is commonly used in hospitals to titrate medications for alcohol withdrawal syndrome (AWS), but may be difficult to apply to intensive care unit (ICU) patients who are too sick or otherwise unable to communicate. Objectives To evaluate the frequency of CIWA-Ar monitoring among ICU patients with AWS and variation in CIWA-Ar monitoring across patient demographic and clinical characteristics. Methods The study included all adults admitted to an ICU in 2017 after treatment for AWS in the Emergency Department of an academic hospital that standardly uses the CIWA-Ar to assess AWS severity and response to treatment. Demographic and clinical data, including Richmond Agitation-Sedation Scale (RASS) assessments (an alternative measure of agitation/sedation), were obtained via chart review. Associations between patient characteristics and CIWA-Ar monitoring were tested using logistic regression. Results After treatment for AWS, only 56% (n = 54/97) of ICU patients were evaluated using the CIWA-Ar; 94% of patients had a documented RASS assessment (n = 91/97). Patients were significantly less likely to receive CIWA-Ar monitoring if they were intubated or identified as Black. Conclusions CIWA-Ar monitoring was used inconsistently in ICU patients with AWS and completed less often in those who were intubated or identified as Black. These hypothesis-generating findings raise questions about the utility of the CIWA-Ar in ICU settings. Future studies should assess alternative measures for titrating AWS medications in the ICU that do not require verbal responses from patients and further explore the association of race with AWS monitoring.


Author(s):  
Nayely García-Méndez ◽  
Miguel Briceño-Santana ◽  
Armando Totomoch-Serra ◽  
Carlos Manterola ◽  
Tamara Otzen ◽  
...  

2002 ◽  
Vol 24 (3) ◽  
pp. 446-454 ◽  
Author(s):  
Sven Ulrich ◽  
Peter Danos ◽  
Bruno Baumann ◽  
Dörthe Müller ◽  
Dörthe Lehmann ◽  
...  

1990 ◽  
Vol 73 (3A) ◽  
pp. NA-NA
Author(s):  
Thomas Hell ◽  
Dirk Martens ◽  
Klaus Eyrlch

Sign in / Sign up

Export Citation Format

Share Document